✦ LIBER ✦

Combined use of goserelin (zoladex) and anastrozole (arimidex) as second-line endocrine therapy in premenopausal women with advanced breast cancer — a study of its clinical and endocrine effects

✍ Scribed by K.L. Cheung; D.P. Forward; L. Jackson; J.F.R. Robertson

Book ID: 117657601
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 135 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)80055-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined endocrine effects of LHRH agoni

Combined endocrine effects of LHRH agonist (Zoladex®) and tamoxifen (Nolvadex®) therapy in premenopausal women with breast cancer

✍ Mr J. F. R. Robertson; K. J. Walker; R. I. Nicholson; R. W. Blamey 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 2 views

Abstract In premenopausal women with breast cancer, the use of the luteinizing hormone releasing hormone agonist, goserelin, results in the production of serum levels of oestradiol equivalent to those after surgical oöphorectomy or in postmenopausal women. The standard first line hormonal treatment

The clinical and endocrine effects of 4-

The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer

✍ Stein, RC; Dowsett, M; Hedley, A; Gazet, J-C; Ford, HT; Coombes, RC 📂 Article 📅 1990 🏛 Nature Publishing Group 🌐 English ⚖ 970 KB

Endocrine effects of combined somatostat

Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer

✍ Andrea Manni; Alice E. Boucher; Laurence M. Demers; Harold A. Harvey; Allan Lipt 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 752 KB

Role of Goserelin in Combination with En

Role of Goserelin in Combination with Endocrine Therapy for the Treatment of Advanced Breast Cancer in Premenopausal Women Positive for Hormone Receptor: A Retrospective Matched Case–Control Study

✍ Wu, Sangang; Li, Qun; Zhu, Yuliang; Sun, Jiayuan; Li, Fengyan; Lin, Huanxin; Gua 📂 Article 📅 2013 🏛 Mary Ann Liebert 🌐 English ⚖ 216 KB

Responses to Tamoxifen withdrawal and se

Responses to Tamoxifen withdrawal and second line endocrine therapy — Clinical clues to the mechanisms of Tamoxifen failure in patients with advanced breast cancer

✍ DeFriend, DJ; Dodwell, DJ; Anderson, H; Howell, A 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Continued use of goserelin to achieve ov

Continued use of goserelin to achieve ovarian function suppression in combination with a further aromatase inhibitor (exemestane) following prior treatment with anastrozole and/or tamoxifen in premenopausal women with oestrogen receptor positive advanced breast cancer

✍ A. Agrawal; Robertson; L. Winterbottom; K. Cheung 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 266 KB